Genetically modified null MC4R mice models exhibit obesity, insulin resistance, nonalcoholic steatohepatitis (NASH), nonalcoholic fatty liver disease (NAFLD), fibrosis, and hepatocellular carcinoma (HCC). Here, MC4R is linked to metabolic dysfunction-associated steatohepatitis.